GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants [Antiviral Agents]

Delino, N. S., Aoki, M., Hayashi, H., Hattori, S.-i., Chang, S. B., Takamatsu, Y., Martyr, C. D., Das, D., Ghosh, A. K., Mitsuya, H.
The American Society for Microbiology (ASM)
Published 2018